Outsourced Pharma: The Pharmacological Treatment Pipeline For Traumatic Brain Injury
By Maddy Pliskin and Mavra Nasir, Back Bay Life Science Advisors
Traumatic brain injury (TBI) is defined as brain damage and dysfunction caused by an external physical force, often from sports injuries, car accidents, and falls. The global annual incidence for TBI is ~69 million, however, the majority of cases go undiagnosed . . .
There is significant unmet need for TBI therapies, leading to increased R&D efforts to discover new treatment approaches. Back Bay Life Science Advisors analyzed the clinical pipeline for new molecular entities at the proprietary level for TBI treatment to better understand the development landscape.
Read the article on Outsourced Pharma.